Evogen Reports Second Quarter and First Half 2013 Financial Results
8/19/2013 6:24:07 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Evogene Ltd. (TASE: EVGN), a leader in plant genomics underlying crop productivity for the food, feed and biofuel industries, today announced its financial results for the second quarter and half year ended June 30, 2013.
Ofer Haviv, Evogene's President and CEO, stated: “The second quarter of this year saw significant progress and achievements as we further broadened our unique discovery and validation capabilities supporting our four market focused operating divisions, and continued to successfully meet objectives for both our partnered and Evogene sponsored product programs.”
Hey, check out all the research scientist jobs. Post your resume today!